The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: Findings from the European Schizophrenia Cohort (EuroSC)

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 7, 2012, Pages 607-616

  Carrà, Giuseppe ^a   Johnson, Sonia ^a   Bebbington, Paul ^a   Angermeyer, Matthias C ^b   Heider, Dirk ^b   Brugha, Traolach ^c   Azorin, Jean Michel ^d   Toumi, Mondher ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e Lundbeck   (France)

Author keywords

Cross sectional study; Dual diagnosis; Europe; Prevalence study; Schizophrenia

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DSM-IV; EUROPE; FEMALE; FRANCE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SUBSTANCE ABUSE; UNITED KINGDOM;

COHORT STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EUROPE; FEMALE; HUMANS; MALE; PREVALENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84865976498     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-012-0305-z     Document Type: Article

References (38)

1. Crawford V, Crome IB, Clancy C (2003) Co-existing problems of mental health and substance misuse (Dual Diagnosis): a literature review. Drugs 10:1-74
2. Regier DA, Farmer ME, Rae DS (1990) Co-morbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) study.JAMA264:2511-2518
3. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ (1996) The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatr 66:17-31 (Pubitemid 26031236)
4. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA (2006) Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis 194:164-172
5. Mueser KT, Essock SM, Drake RE, Wolfe R, Frisman L (2001) Rural and urban differences in patients with a dual diagnosis. Schizophr Res 48:93-107 (Pubitemid 32241186)
6. Carrà G, Johnson S (2009) Variations in rates of comorbid substance use in psychosis between geographical areas and mental health settings in the UK. Soc Psychiatr Psychiatr Epidemiol 44:429-447
7. Soyka M, Albus M, Kathmann N, Finelli A, Hofstetter S, Holzbach R, Immler B, Sand P (2003) Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur Arch Psychiatr Clin Neurosci 242:362-372
8. Dervaux A, Laqueille X, Bourdel MC (2003) Cannabis and schizophrenia: demographic and clinical correlates. Encephale 29:11-17 (Pubitemid 36361972)
9. Corcoran CM, Kimhy D, Stanford A, Khan S, Walsh J, Thompson J, Schobel S, Harkavy-Friedman J, Goetz R, Colibazzi T, Cressman V, Malaspina D (2008) Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophr Res 106:286-293
10. Foti DJ, Kotov R, Guey LT, Bromet EJ (2010) Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatr 167:987-993
11. Drake RE, Alterman AI, Rosenberg SR (1993) Detection of substance use disorders in severely mentally ill patients. Community Ment Health J 29:175-192 (Pubitemid 23139574)
12. Goldfinger SM, Schutt RK, Seidman LJ, Turner WM, Penk WE, Tolomiczenko GS (1996) Self-report and observer measures of substance abuse among homeless mentally ill persons in the cross-section and over time. J Nerv Ment Dis 184:667-672 (Pubitemid 27006437)
13. Potvin S, Sepehry AA, Stip E (2006) A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med 36: 431-440 (Pubitemid 43380996)
14. Furr-Holden CD, Anthony JC (2003) Epidemiologic differences in drug dependence: a US-UK cross-national comparison. Soc Psychiatr Psychiatr Epidemiol 38:165-172 (Pubitemid 37160780)
15. Rehm J, Room R, van den Brink W, Jacobi F (2005) Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol 15:377-388 (Pubitemid 40943542)
16. RehmJ,RoomR, van den BrinkW, Jacobi F (2005)Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol 15:389-397 (Pubitemid 40943543)
17. European Monitoring Centre for Drugs and Drug Addiction- EMCDDA (2010) The state of the drugs problem in the European Union and Norway. Office for Official Publications of the European Communities, Luxembourg
18. Bebbington PE, Angermeyer M, Azorin JM, Brugha T, Kilian R, Johnson S, Toumi M, Kornfeld A (2005) The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study. Soc Psychiatr Psychiatr Epidemiol 40:707-717 (Pubitemid 41479058)
19. World Health Organization (1973) The international pilot study of schizophrenia. WHO Press, Geneva
20. Jablensky A, Schwarz R, Tomov T (1980) WHO Collaborative Study on impairments and disabilities associated with schizophrenic disorders. Acta Psychiatr Scand 285(suppl 62):152-159
21. World Health Organization (1992) SCAN: schedules for clinical assessment in neuropsychiatry. WHO Press, Geneva
22. Spitzer RL, Williams JB, Gibbon M, First MB (1992) The structured clinical interview for DSM-III-R (SCID). I: rationale, and description. Arch Gen Psychiatr 49:624-629
23. Hasin D, Hatzenbuehler ML, Keyes K, Ogburn E (2006) Substance use disorders: diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) and international classification of diseases, tenth edition (ICD-10). Addiction 101:59-75 (Pubitemid 44199497)
24. Marwaha S, Johnson S, Bebbington P, Stafford M, Angermeyer MC, Brugha T, Azorin JM, Kilian R, Hansen K, Toumi M (2007) Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatr 191:30-37 (Pubitemid 47035178)
25. Norström T (2001) Per capita alcohol consumption and all-cause mortality in 14 European countries. Addiction 96(suppl 1): 113-128
26. World Health Organisation (2010) Global strategy to reduce the harmful use of alcohol. WHO Press, Geneva
27. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N (1990) Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatr 47:589-593 (Pubitemid 20189971)
28. Tomov T, Nikolov V (1990) Reliability of SCAN categories and scores: results of the field trials. In: Stefanis CN, Rabavilas AD, Soldatos CR (eds) Psychiatry: a world perspective. Excerpta Medica, Amsterdam, vol 1, pp 107-112
29. European Monitoring Centre for Drugs and Drug Addiction- EMCDDA (2003) The state of the drugs problem in the European Union and Norway. Office for Official Publications of the European Communities, Luxembourg
30. McCrone P, Menezes PR, Johnson S, Scott H, Thornicroft G, Marshall J, Bebbington P, Kuipers E (2000) Service use and costs of people with dual diagnosis in South London. Acta Psychiatr Scand 101:464-472 (Pubitemid 30365569)
31. Johnson S, Thornicroft G, Afuwape S, Leese M, White IR, Hughes E, Wanigaratne S, Miles H, Craig T (2007) Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study) - cluster randomised trial. Br J Psychiatr 191:451-452 (Pubitemid 350069588)
32. Craig TKJ, Johnson S, McCrone P, Afuwape S, Hughes E, Gournay K, White I, Wanigaratne S, Leese M, Thornicroft G (2008) Integrated care for co-occurring disorders: psychiatric symptoms, social functioning, and service costs at 18 months. Psychiatr Serv 59:276-282
33. Hughes E, Wanigaratne S, Gournay K, Johnson S, Thornicroft G, Finch E, Marshall J, Smith N (2008) Training in dual diagnosis interventions (the COMO Study): randomised controlled trial. BMC Psychiatr. doi:10.1186/1471-244X-8-12 (Pubitemid 351486695)
34. Altamura AC, Serati M, Albano A, Paoli RA, Glick ID, Dell'Osso B (2011) An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur Arch Psychiatr Clin Neurosci 261:489-508
35. Heider D, Bernert S, König HH, Matschinger H, Hogh T, Brugha TS, Bebbington PE, Azorin M, Angermeyer MC, Toumi M (2009) Medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - Findings from the European Schizophrenia Cohort (EuroSC). Eur Psychiatr 24:216-224
36. Fowler IL, Carr VJ, Carter NT, Lewin TJ (1998) Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 24:443-455 (Pubitemid 28378229)
37. Lagerberg TV, Sundet K, Aminoff SR, Berg AO, Ringen PA, Andreassen OA, Melle I (2011) Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur Arch Psychiatr Clin Neurosci 261:397-405
38. Pompili M, Serafini G, Innamorati M, Biondi M, Siracusano A, Di Giannantonio M, Giupponi G, Amore M, Lester D, Girardi P, Möller- Leimkühler AM (2012) Substance abuse and suicide risk among adolescents. Eur Arch Psychiatr Clin Neurosci. doi: 10.1007/s00406-012-0292-0